Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP123013.RA81jZ7nMO3OgYwU6FQbA9nqly77MpL-LfjZIh0KcLnJ8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP123013.RA81jZ7nMO3OgYwU6FQbA9nqly77MpL-LfjZIh0KcLnJ8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP123013.RA81jZ7nMO3OgYwU6FQbA9nqly77MpL-LfjZIh0KcLnJ8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP123013.RA81jZ7nMO3OgYwU6FQbA9nqly77MpL-LfjZIh0KcLnJ8130_provenance.
- NP123013.RA81jZ7nMO3OgYwU6FQbA9nqly77MpL-LfjZIh0KcLnJ8130_assertion description "[A carboxylesterase 2 gene polymorphism as predictor of capecitabine on response and time to progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123013.RA81jZ7nMO3OgYwU6FQbA9nqly77MpL-LfjZIh0KcLnJ8130_provenance.
- NP123013.RA81jZ7nMO3OgYwU6FQbA9nqly77MpL-LfjZIh0KcLnJ8130_assertion evidence source_evidence_literature NP123013.RA81jZ7nMO3OgYwU6FQbA9nqly77MpL-LfjZIh0KcLnJ8130_provenance.
- NP123013.RA81jZ7nMO3OgYwU6FQbA9nqly77MpL-LfjZIh0KcLnJ8130_assertion SIO_000772 18473752 NP123013.RA81jZ7nMO3OgYwU6FQbA9nqly77MpL-LfjZIh0KcLnJ8130_provenance.
- NP123013.RA81jZ7nMO3OgYwU6FQbA9nqly77MpL-LfjZIh0KcLnJ8130_assertion wasDerivedFrom gad-20150221 NP123013.RA81jZ7nMO3OgYwU6FQbA9nqly77MpL-LfjZIh0KcLnJ8130_provenance.
- NP123013.RA81jZ7nMO3OgYwU6FQbA9nqly77MpL-LfjZIh0KcLnJ8130_assertion wasGeneratedBy ECO_0000203 NP123013.RA81jZ7nMO3OgYwU6FQbA9nqly77MpL-LfjZIh0KcLnJ8130_provenance.
- gad-20150221 importedOn "2015-02-21" NP123013.RA81jZ7nMO3OgYwU6FQbA9nqly77MpL-LfjZIh0KcLnJ8130_provenance.